Aveanna Healthcare Holdings, Inc.

How big is Aveanna Healthcare Holdings, Inc.?

As of Jun 18, Aveanna Healthcare Holdings, Inc. has a market capitalization of 942.30 million and reported net sales of 2,093.07 million with a net profit of 5.44 million over the latest four quarters.

Market Cap: As of Jun 18, Aveanna Healthcare Holdings, Inc. has a market capitalization of 942.30 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Aveanna Healthcare reported net sales of 2,093.07 million and a net profit of 5.44 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company's shareholder's funds were reported at -123.55 million, while total assets amounted to 1,680.57 million.

What does Aveanna Healthcare Holdings, Inc. do?

Aveanna Healthcare Holdings, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, with recent net sales of $559 million and a net profit of $5 million. Its market cap is approximately $942.30 million, with a P/E ratio of 25.00 and a negative return on equity of -43.55%.

Overview: <BR>Aveanna Healthcare Holdings, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 559 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 5 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 942.30 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 25.00 <BR>Debt Equity: -13.90 <BR>Return on Equity: -43.55% <BR>Price to Book: -9.41 <BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Should I buy, sell or hold Aveanna Healthcare Holdings, Inc.?

Is Aveanna Healthcare Holdings, Inc. overvalued or undervalued?

As of March 28, 2022, Aveanna Healthcare Holdings, Inc. is considered risky and overvalued with a high P/E ratio of 31.16 compared to its peers, despite outperforming the S&P 500 with a 59.92% return over the past year.

As of 28 March 2022, the valuation grade for Aveanna Healthcare Holdings, Inc. moved from does not qualify to risky. The company appears to be overvalued based on its current metrics. The P/E ratio stands at 25, significantly higher than the industry average, while the EV to EBITDA ratio is 11.90, indicating a premium valuation. Additionally, the PEG ratio is exceptionally low at 0.01, suggesting that the stock may not be justified at its current price given its growth prospects.<BR><BR>In comparison to peers, Aveanna's P/E ratio of 31.16 is notably higher than Pediatrix Medical Group, Inc., which has a P/E of 9.83 and is rated very attractive. The Pennant Group, Inc. also presents a more favorable valuation with a P/E of 26.98 and a fair rating. Furthermore, Aveanna's stock has outperformed the S&P 500 significantly over the past year, returning 59.92% compared to the index's 17.14%, which may reflect investor optimism despite the high valuation metrics.

Is Aveanna Healthcare Holdings, Inc. technically bullish or bearish?

As of August 26, 2025, Aveanna Healthcare Holdings, Inc. is in a bullish trend supported by strong technical indicators, despite a bearish weekly RSI, with a year-to-date return of 85.12% compared to the S&P 500's 12.22%.

As of 26 August 2025, the technical trend for Aveanna Healthcare Holdings, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view, including bullish signals from the MACD on both weekly and monthly time frames, as well as bullish Bollinger Bands. The daily moving averages also indicate a bullish trend. However, the weekly RSI is bearish, which suggests some caution. Multi-period returns show the stock significantly outperforming the S&P 500, with a year-to-date return of 85.12% compared to the S&P 500's 12.22%, and a three-year return of 345.26% versus 70.41%. Overall, the strength of the bullish trend is reinforced by the positive returns and the majority of technical indicators.